Global Dengue Rapid Test Supply, Demand and Key Producers, 2026-2032

May 2026 | 129 pages | ID: GAE62EE5EC56EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Dengue Rapid Test market size is expected to reach $ 971 million by 2032, rising at a market growth of 6.1% CAGR during the forecast period (2026-2032).

Dengue Rapid Test is an in vitro diagnostic (IVD) product based on immunochromatography or other rapid immunoassay techniques. It is used to detect antigens or antibodies related to the dengue virus in human samples within a short time (usually 15?20 minutes), thereby enabling rapid screening or auxiliary diagnosis of dengue infection.

Gross Profit Margin Level

As a typical immunochromatographic point-of-care testing (POCT) in vitro diagnostic product, the dengue fever rapid test generally has a mid-to-high gross profit margin in the IVD industry, but exhibits a clear stratified structure. From a supply chain perspective, relying on external procurement for key upstream raw materials such as monoclonal antibodies, recombinant antigens, and membrane materials can constrain costs, while companies with the ability to independently develop core raw materials can typically significantly improve their gross profit margin. In terms of business models, the OEM/white-label supply model, due to intense price competition and orders primarily based on large-volume bidding, generally has a gross profit margin of approximately 35%?50%; while the own-brand + registration and certification + channel distribution model can achieve a gross profit margin of around 50%?65%; further entry into hospital terminals, government projects, and international organization procurement systems, through brand premium and technological endorsement, can further increase the gross profit margin. In addition, the industry's gross profit margin is also affected by the fluctuations of the pandemic cycle, regional price systems (significant differences between developed and developing countries), and channel levels (direct sales or multi-level distribution). Overall, dengue fever rapid testing is not a 'low-end test strip' business, but rather a structurally driven industry where profitability is determined by raw material capabilities, registration capabilities, and distribution channels.

Industry Drivers

The core growth of the dengue fever rapid testing industry stems from the dual drivers of 'disease spread + early diagnosis.' On the one hand, with climate change, accelerated urbanization, and the expansion of mosquito vector distribution, the geographical coverage of dengue fever continues to expand, with an increasing incidence and case size, providing a long-term, rigid foundation for testing demand. On the other hand, healthcare systems are shifting from 'confirmatory diagnosis' to 'screening diagnosis,' especially in tropical and subtropical regions, where primary healthcare institutions and public health systems are increasingly reliant on rapid, low-cost, point-of-care testing (POCT) methods. Simultaneously, the increasing clinical demand for early diagnosis has also driven the widespread adoption of NS1 antigen and antibody combination tests, thereby improving testing coverage. Furthermore, the continued expansion of public health projects led by international organizations and governments (such as epidemic surveillance, emergency stockpiling, and large-scale screening) provides a stable source of demand for the industry. With the added trend of multi-pathogen testing (such as dengue fever + Zika + chikungunya), the industry is upgrading from single testing products to platform-based and combined solutions. Overall, the industry's growth is not driven by short-term epidemics, but rather by a medium- to long-term expansion logic shaped by changes in epidemiology, upgrades to primary healthcare systems, and increased investment in public health.

This report studies the global Dengue Rapid Test demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Dengue Rapid Test, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Dengue Rapid Test that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Dengue Rapid Test total market, 2021-2032, (USD Million)
Global Dengue Rapid Test total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Dengue Rapid Test total market, key domestic companies, and share, (USD Million)
Global Dengue Rapid Test revenue by player, revenue and market share 2021-2026, (USD Million)
Global Dengue Rapid Test total market by Type, CAGR, 2021-2032, (USD Million)
Global Dengue Rapid Test total market by Application, CAGR, 2021-2032, (USD Million)

This report profiles major players in the global Dengue Rapid Test market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Abbott, SD Biosensor, bioM?rieux, CTK Biotech, Wondfo, Roche Diagnostics, ACON Biotech, InBios International, CTK Biotech, Bio-Rad Laboratories, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Dengue Rapid Test market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.

Global Dengue Rapid Test Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Dengue Rapid Test Market, Segmentation by Type:
  • NS1 Antigen Detection
  • IgM Antibody Detection
  • IgG Antibody Detection
  • Others
Global Dengue Rapid Test Market, Segmentation by Technical Principles:
  • Colloidal Gold Immunochromatography
  • ELISA
  • Latex Agglutination
  • Others
Global Dengue Rapid Test Market, Segmentation by Product Form:
  • Test Cards
  • Test Strips
  • Microplates
  • Others
Global Dengue Rapid Test Market, Segmentation by Application:
  • Healthcare Industry
  • Public Health Sector
  • Others
Companies Profiled:
  • Abbott
  • SD Biosensor
  • bioM?rieux
  • CTK Biotech
  • Wondfo
  • Roche Diagnostics
  • ACON Biotech
  • InBios International
  • CTK Biotech
  • Bio-Rad Laboratories
  • DiaSorin Group
  • Siemens Healthineers
  • Thermo Fisher Scientific
  • Reszon Diagnostics International
Key Questions Answered
1. How big is the global Dengue Rapid Test market?
2. What is the demand of the global Dengue Rapid Test market?
3. What is the year over year growth of the global Dengue Rapid Test market?
4. What is the total value of the global Dengue Rapid Test market?
5. Who are the Major Players in the global Dengue Rapid Test market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Dengue Rapid Test Introduction
1.2 World Dengue Rapid Test Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Dengue Rapid Test Total Market by Region (by Headquarter Location)
  1.3.1 World Dengue Rapid Test Market Size by Region (2021-2032), (by Headquarter Location)
  1.3.2 United States Based Company Dengue Rapid Test Revenue (2021-2032)
  1.3.3 China Based Company Dengue Rapid Test Revenue (2021-2032)
  1.3.4 Europe Based Company Dengue Rapid Test Revenue (2021-2032)
  1.3.5 Japan Based Company Dengue Rapid Test Revenue (2021-2032)
  1.3.6 South Korea Based Company Dengue Rapid Test Revenue (2021-2032)
  1.3.7 ASEAN Based Company Dengue Rapid Test Revenue (2021-2032)
  1.3.8 India Based Company Dengue Rapid Test Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Dengue Rapid Test Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Major Market Trends

2 DEMAND SUMMARY

2.1 World Dengue Rapid Test Consumption Value (2021-2032)
2.2 World Dengue Rapid Test Consumption Value by Region
  2.2.1 World Dengue Rapid Test Consumption Value by Region (2021-2026)
  2.2.2 World Dengue Rapid Test Consumption Value Forecast by Region (2027-2032)
2.3 United States Dengue Rapid Test Consumption Value (2021-2032)
2.4 China Dengue Rapid Test Consumption Value (2021-2032)
2.5 Europe Dengue Rapid Test Consumption Value (2021-2032)
2.6 Japan Dengue Rapid Test Consumption Value (2021-2032)
2.7 South Korea Dengue Rapid Test Consumption Value (2021-2032)
2.8 ASEAN Dengue Rapid Test Consumption Value (2021-2032)
2.9 India Dengue Rapid Test Consumption Value (2021-2032)

3 WORLD DENGUE RAPID TEST COMPANIES COMPETITIVE ANALYSIS

3.1 World Dengue Rapid Test Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Dengue Rapid Test Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Dengue Rapid Test in 2025
  3.2.3 Global Concentration Ratios (CR8) for Dengue Rapid Test in 2025
3.3 Dengue Rapid Test Company Evaluation Quadrant
3.4 Dengue Rapid Test Market: Overall Company Footprint Analysis
  3.4.1 Dengue Rapid Test Market: Region Footprint
  3.4.2 Dengue Rapid Test Market: Company Product Type Footprint
  3.4.3 Dengue Rapid Test Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Dengue Rapid Test Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Dengue Rapid Test Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
  4.1.2 United States VS China: Dengue Rapid Test Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Dengue Rapid Test Consumption Value Comparison
  4.2.1 United States VS China: Dengue Rapid Test Consumption Value Comparison (2021 & 2025 & 2032)
  4.2.2 United States VS China: Dengue Rapid Test Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Dengue Rapid Test Companies and Market Share, 2021-2026
  4.3.1 United States Based Dengue Rapid Test Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Dengue Rapid Test Revenue, (2021-2026)
4.4 China Based Companies Dengue Rapid Test Revenue and Market Share, 2021-2026
  4.4.1 China Based Dengue Rapid Test Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Dengue Rapid Test Revenue, (2021-2026)
4.5 Rest of World Based Dengue Rapid Test Companies and Market Share, 2021-2026
  4.5.1 Rest of World Based Dengue Rapid Test Companies, Headquarters (Province, Country)
  4.5.2 Rest of World Based Companies Dengue Rapid Test Revenue (2021-2026)

5 MARKET ANALYSIS BY TYPE

5.1 World Dengue Rapid Test Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
  5.2.1 NS1 Antigen Detection
  5.2.2 IgM Antibody Detection
  5.2.3 IgG Antibody Detection
  5.2.4 Others
5.3 Market Segment by Type
  5.3.1 World Dengue Rapid Test Market Size by Type (2021-2026)
  5.3.2 World Dengue Rapid Test Market Size by Type (2027-2032)
  5.3.3 World Dengue Rapid Test Market Size Market Share by Type (2027-2032)

6 MARKET ANALYSIS BY TECHNICAL PRINCIPLES

6.1 World Dengue Rapid Test Market Size Overview by Technical Principles: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Technical Principles
  6.2.1 Colloidal Gold Immunochromatography
  6.2.2 ELISA
  6.2.3 Latex Agglutination
  6.2.4 Others
6.3 Market Segment by Technical Principles
  6.3.1 World Dengue Rapid Test Market Size by Technical Principles (2021-2026)
  6.3.2 World Dengue Rapid Test Market Size by Technical Principles (2027-2032)
  6.3.3 World Dengue Rapid Test Market Size Market Share by Technical Principles (2027-2032)

7 MARKET ANALYSIS BY PRODUCT FORM

7.1 World Dengue Rapid Test Market Size Overview by Product Form: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Product Form
  7.2.1 Test Cards
  7.2.2 Test Strips
  7.2.3 Microplates
  7.2.4 Others
7.3 Market Segment by Product Form
  7.3.1 World Dengue Rapid Test Market Size by Product Form (2021-2026)
  7.3.2 World Dengue Rapid Test Market Size by Product Form (2027-2032)
  7.3.3 World Dengue Rapid Test Market Size Market Share by Product Form (2027-2032)

8 MARKET ANALYSIS BY APPLICATION

8.1 World Dengue Rapid Test Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
  8.2.1 Healthcare Industry
  8.2.2 Public Health Sector
  8.2.3 Others
8.3 Market Segment by Application
  8.3.1 World Dengue Rapid Test Market Size by Application (2021-2026)
  8.3.2 World Dengue Rapid Test Market Size by Application (2027-2032)
  8.3.3 World Dengue Rapid Test Market Size Market Share by Application (2021-2032)

9 COMPANY PROFILES

9.1 Abbott
  9.1.1 Abbott Details
  9.1.2 Abbott Major Business
  9.1.3 Abbott Dengue Rapid Test Product and Services
  9.1.4 Abbott Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.1.5 Abbott Recent Developments/Updates
  9.1.6 Abbott Competitive Strengths & Weaknesses
9.2 SD Biosensor
  9.2.1 SD Biosensor Details
  9.2.2 SD Biosensor Major Business
  9.2.3 SD Biosensor Dengue Rapid Test Product and Services
  9.2.4 SD Biosensor Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.2.5 SD Biosensor Recent Developments/Updates
  9.2.6 SD Biosensor Competitive Strengths & Weaknesses
9.3 bioM?rieux
  9.3.1 bioM?rieux Details
  9.3.2 bioM?rieux Major Business
  9.3.3 bioM?rieux Dengue Rapid Test Product and Services
  9.3.4 bioM?rieux Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.3.5 bioM?rieux Recent Developments/Updates
  9.3.6 bioM?rieux Competitive Strengths & Weaknesses
9.4 CTK Biotech
  9.4.1 CTK Biotech Details
  9.4.2 CTK Biotech Major Business
  9.4.3 CTK Biotech Dengue Rapid Test Product and Services
  9.4.4 CTK Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.4.5 CTK Biotech Recent Developments/Updates
  9.4.6 CTK Biotech Competitive Strengths & Weaknesses
9.5 Wondfo
  9.5.1 Wondfo Details
  9.5.2 Wondfo Major Business
  9.5.3 Wondfo Dengue Rapid Test Product and Services
  9.5.4 Wondfo Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.5.5 Wondfo Recent Developments/Updates
  9.5.6 Wondfo Competitive Strengths & Weaknesses
9.6 Roche Diagnostics
  9.6.1 Roche Diagnostics Details
  9.6.2 Roche Diagnostics Major Business
  9.6.3 Roche Diagnostics Dengue Rapid Test Product and Services
  9.6.4 Roche Diagnostics Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.6.5 Roche Diagnostics Recent Developments/Updates
  9.6.6 Roche Diagnostics Competitive Strengths & Weaknesses
9.7 ACON Biotech
  9.7.1 ACON Biotech Details
  9.7.2 ACON Biotech Major Business
  9.7.3 ACON Biotech Dengue Rapid Test Product and Services
  9.7.4 ACON Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.7.5 ACON Biotech Recent Developments/Updates
  9.7.6 ACON Biotech Competitive Strengths & Weaknesses
9.8 InBios International
  9.8.1 InBios International Details
  9.8.2 InBios International Major Business
  9.8.3 InBios International Dengue Rapid Test Product and Services
  9.8.4 InBios International Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.8.5 InBios International Recent Developments/Updates
  9.8.6 InBios International Competitive Strengths & Weaknesses
9.9 CTK Biotech
  9.9.1 CTK Biotech Details
  9.9.2 CTK Biotech Major Business
  9.9.3 CTK Biotech Dengue Rapid Test Product and Services
  9.9.4 CTK Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.9.5 CTK Biotech Recent Developments/Updates
  9.9.6 CTK Biotech Competitive Strengths & Weaknesses
9.10 Bio-Rad Laboratories
  9.10.1 Bio-Rad Laboratories Details
  9.10.2 Bio-Rad Laboratories Major Business
  9.10.3 Bio-Rad Laboratories Dengue Rapid Test Product and Services
  9.10.4 Bio-Rad Laboratories Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.10.5 Bio-Rad Laboratories Recent Developments/Updates
  9.10.6 Bio-Rad Laboratories Competitive Strengths & Weaknesses
9.11 DiaSorin Group
  9.11.1 DiaSorin Group Details
  9.11.2 DiaSorin Group Major Business
  9.11.3 DiaSorin Group Dengue Rapid Test Product and Services
  9.11.4 DiaSorin Group Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.11.5 DiaSorin Group Recent Developments/Updates
  9.11.6 DiaSorin Group Competitive Strengths & Weaknesses
9.12 Siemens Healthineers
  9.12.1 Siemens Healthineers Details
  9.12.2 Siemens Healthineers Major Business
  9.12.3 Siemens Healthineers Dengue Rapid Test Product and Services
  9.12.4 Siemens Healthineers Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.12.5 Siemens Healthineers Recent Developments/Updates
  9.12.6 Siemens Healthineers Competitive Strengths & Weaknesses
9.13 Thermo Fisher Scientific
  9.13.1 Thermo Fisher Scientific Details
  9.13.2 Thermo Fisher Scientific Major Business
  9.13.3 Thermo Fisher Scientific Dengue Rapid Test Product and Services
  9.13.4 Thermo Fisher Scientific Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.13.5 Thermo Fisher Scientific Recent Developments/Updates
  9.13.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
9.14 Reszon Diagnostics International
  9.14.1 Reszon Diagnostics International Details
  9.14.2 Reszon Diagnostics International Major Business
  9.14.3 Reszon Diagnostics International Dengue Rapid Test Product and Services
  9.14.4 Reszon Diagnostics International Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026)
  9.14.5 Reszon Diagnostics International Recent Developments/Updates
  9.14.6 Reszon Diagnostics International Competitive Strengths & Weaknesses

10 INDUSTRY CHAIN ANALYSIS

10.1 Dengue Rapid Test Industry Chain
10.2 Dengue Rapid Test Upstream Analysis
10.3 Dengue Rapid Test Midstream Analysis
10.4 Dengue Rapid Test Downstream Analysis

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer


LIST OF TABLES

Table 1. World Dengue Rapid Test Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Dengue Rapid Test Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Dengue Rapid Test Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Dengue Rapid Test Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Dengue Rapid Test Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Dengue Rapid Test Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Dengue Rapid Test Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Dengue Rapid Test Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Dengue Rapid Test Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Dengue Rapid Test Players in 2025
Table 12. World Dengue Rapid Test Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Dengue Rapid Test Company Evaluation Quadrant
Table 14. Head Office of Key Dengue Rapid Test Players
Table 15. Dengue Rapid Test Market: Company Product Type Footprint
Table 16. Dengue Rapid Test Market: Company Product Application Footprint
Table 17. Dengue Rapid Test Mergers & Acquisitions Activity
Table 18. United States VS China Dengue Rapid Test Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Dengue Rapid Test Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Dengue Rapid Test Companies, Headquarters (States, Country)
Table 21. United States Based Companies Dengue Rapid Test Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Dengue Rapid Test Revenue Market Share (2021-2026)
Table 23. China Based Dengue Rapid Test Companies, Headquarters (Province, Country)
Table 24. China Based Companies Dengue Rapid Test Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Dengue Rapid Test Revenue Market Share (2021-2026)
Table 26. Rest of World Based Dengue Rapid Test Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Dengue Rapid Test Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Dengue Rapid Test Revenue Market Share (2021-2026)
Table 29. World Dengue Rapid Test Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Dengue Rapid Test Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Dengue Rapid Test Market Size by Type (2027-2032) & (USD Million)
Table 32. World Dengue Rapid Test Market Size by Technical Principles, (USD Million), 2021 & 2025 & 2032
Table 33. World Dengue Rapid Test Market Size Value by Technical Principles (2021-2026) & (USD Million)
Table 34. World Dengue Rapid Test Market Size by Technical Principles (2027-2032) & (USD Million)
Table 35. World Dengue Rapid Test Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Table 36. World Dengue Rapid Test Market Size Value by Product Form (2021-2026) & (USD Million)
Table 37. World Dengue Rapid Test Market Size by Product Form (2027-2032) & (USD Million)
Table 38. World Dengue Rapid Test Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Dengue Rapid Test Market Size by Application (2021-2026) & (USD Million)
Table 40. World Dengue Rapid Test Market Size by Application (2027-2032) & (USD Million)
Table 41. Abbott Basic Information, Manufacturing Base and Competitors
Table 42. Abbott Major Business
Table 43. Abbott Dengue Rapid Test Product and Services
Table 44. Abbott Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Abbott Recent Developments/Updates
Table 46. Abbott Competitive Strengths & Weaknesses
Table 47. SD Biosensor Basic Information, Manufacturing Base and Competitors
Table 48. SD Biosensor Major Business
Table 49. SD Biosensor Dengue Rapid Test Product and Services
Table 50. SD Biosensor Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. SD Biosensor Recent Developments/Updates
Table 52. SD Biosensor Competitive Strengths & Weaknesses
Table 53. bioM?rieux Basic Information, Manufacturing Base and Competitors
Table 54. bioM?rieux Major Business
Table 55. bioM?rieux Dengue Rapid Test Product and Services
Table 56. bioM?rieux Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. bioM?rieux Recent Developments/Updates
Table 58. bioM?rieux Competitive Strengths & Weaknesses
Table 59. CTK Biotech Basic Information, Manufacturing Base and Competitors
Table 60. CTK Biotech Major Business
Table 61. CTK Biotech Dengue Rapid Test Product and Services
Table 62. CTK Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. CTK Biotech Recent Developments/Updates
Table 64. CTK Biotech Competitive Strengths & Weaknesses
Table 65. Wondfo Basic Information, Manufacturing Base and Competitors
Table 66. Wondfo Major Business
Table 67. Wondfo Dengue Rapid Test Product and Services
Table 68. Wondfo Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Wondfo Recent Developments/Updates
Table 70. Wondfo Competitive Strengths & Weaknesses
Table 71. Roche Diagnostics Basic Information, Manufacturing Base and Competitors
Table 72. Roche Diagnostics Major Business
Table 73. Roche Diagnostics Dengue Rapid Test Product and Services
Table 74. Roche Diagnostics Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Roche Diagnostics Recent Developments/Updates
Table 76. Roche Diagnostics Competitive Strengths & Weaknesses
Table 77. ACON Biotech Basic Information, Manufacturing Base and Competitors
Table 78. ACON Biotech Major Business
Table 79. ACON Biotech Dengue Rapid Test Product and Services
Table 80. ACON Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. ACON Biotech Recent Developments/Updates
Table 82. ACON Biotech Competitive Strengths & Weaknesses
Table 83. InBios International Basic Information, Manufacturing Base and Competitors
Table 84. InBios International Major Business
Table 85. InBios International Dengue Rapid Test Product and Services
Table 86. InBios International Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. InBios International Recent Developments/Updates
Table 88. InBios International Competitive Strengths & Weaknesses
Table 89. CTK Biotech Basic Information, Manufacturing Base and Competitors
Table 90. CTK Biotech Major Business
Table 91. CTK Biotech Dengue Rapid Test Product and Services
Table 92. CTK Biotech Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. CTK Biotech Recent Developments/Updates
Table 94. CTK Biotech Competitive Strengths & Weaknesses
Table 95. Bio-Rad Laboratories Basic Information, Manufacturing Base and Competitors
Table 96. Bio-Rad Laboratories Major Business
Table 97. Bio-Rad Laboratories Dengue Rapid Test Product and Services
Table 98. Bio-Rad Laboratories Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Bio-Rad Laboratories Recent Developments/Updates
Table 100. Bio-Rad Laboratories Competitive Strengths & Weaknesses
Table 101. DiaSorin Group Basic Information, Manufacturing Base and Competitors
Table 102. DiaSorin Group Major Business
Table 103. DiaSorin Group Dengue Rapid Test Product and Services
Table 104. DiaSorin Group Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. DiaSorin Group Recent Developments/Updates
Table 106. DiaSorin Group Competitive Strengths & Weaknesses
Table 107. Siemens Healthineers Basic Information, Manufacturing Base and Competitors
Table 108. Siemens Healthineers Major Business
Table 109. Siemens Healthineers Dengue Rapid Test Product and Services
Table 110. Siemens Healthineers Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Siemens Healthineers Recent Developments/Updates
Table 112. Siemens Healthineers Competitive Strengths & Weaknesses
Table 113. Thermo Fisher Scientific Basic Information, Manufacturing Base and Competitors
Table 114. Thermo Fisher Scientific Major Business
Table 115. Thermo Fisher Scientific Dengue Rapid Test Product and Services
Table 116. Thermo Fisher Scientific Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Thermo Fisher Scientific Recent Developments/Updates
Table 118. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 119. Reszon Diagnostics International Basic Information, Manufacturing Base and Competitors
Table 120. Reszon Diagnostics International Major Business
Table 121. Reszon Diagnostics International Dengue Rapid Test Product and Services
Table 122. Reszon Diagnostics International Dengue Rapid Test Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Reszon Diagnostics International Recent Developments/Updates
Table 124. Reszon Diagnostics International Competitive Strengths & Weaknesses
Table 125. Global Key Players of Dengue Rapid Test Upstream (Raw Materials)
Table 126. Global Dengue Rapid Test Typical Customers

LIST OF FIGURES

Figure 1. Dengue Rapid Test Picture
Figure 2. World Dengue Rapid Test Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Dengue Rapid Test Total Revenue (2021-2032) & (USD Million)
Figure 4. World Dengue Rapid Test Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Dengue Rapid Test Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Dengue Rapid Test Revenue (2021-2032) & (USD Million)
Figure 13. Dengue Rapid Test Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 16. World Dengue Rapid Test Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 18. China Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 23. India Dengue Rapid Test Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Dengue Rapid Test by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Dengue Rapid Test Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Dengue Rapid Test Markets in 2025
Figure 27. United States VS China: Dengue Rapid Test Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Dengue Rapid Test Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Dengue Rapid Test Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Dengue Rapid Test Market Size Market Share by Type in 2025
Figure 31. NS1 Antigen Detection
Figure 32. IgM Antibody Detection
Figure 33. IgG Antibody Detection
Figure 34. Others
Figure 35. World Dengue Rapid Test Market Size Market Share by Type (2021-2032)
Figure 36. World Dengue Rapid Test Market Size by Technical Principles, (USD Million), 2021 & 2025 & 2032
Figure 37. World Dengue Rapid Test Market Size Market Share by Technical Principles in 2025
Figure 38. Colloidal Gold Immunochromatography
Figure 39. ELISA
Figure 40. Latex Agglutination
Figure 41. Others
Figure 42. World Dengue Rapid Test Market Size Market Share by Technical Principles (2021-2032)
Figure 43. World Dengue Rapid Test Market Size by Product Form, (USD Million), 2021 & 2025 & 2032
Figure 44. World Dengue Rapid Test Market Size Market Share by Product Form in 2025
Figure 45. Test Cards
Figure 46. Test Strips
Figure 47. Microplates
Figure 48. Others
Figure 49. World Dengue Rapid Test Market Size Market Share by Product Form (2021-2032)
Figure 50. World Dengue Rapid Test Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 51. World Dengue Rapid Test Market Size Market Share by Application in 2025
Figure 52. Healthcare Industry
Figure 53. Public Health Sector
Figure 54. Others
Figure 55. World Dengue Rapid Test Market Size Market Share by Application (2021-2032)
Figure 56. Dengue Rapid Test Industrial Chain
Figure 57. Methodology
Figure 58. Research Process and Data Source


More Publications